FibroGen (NASDAQ:FGEN) Upgraded at HC Wainwright

Dec 20, 2024 · NASDAQ:FGEN opened at $0.35 on Tuesday. FibroGen has a 52-week low of $0.18 and a 52-week high of $2.93. The stock has a fifty day moving average of $0.35 and a …

$0.35
OFF

FibroGen (NASDAQ:FGEN) Upgraded At HC Wainwright

2 weeks from now

Dec 20, 2024 · NASDAQ:FGEN opened at $0.35 on Tuesday. FibroGen has a 52-week low of $0.18 and a 52-week high of $2.93. The stock has a fifty day moving average of $0.35 and a …

etfdailynews.com

$32.76
OFF

FibroGen Shares Rating Initiated With Buy On Product Potential

2 weeks from now

Dec 17, 2024 · On Tuesday, H.C. Wainwright initiated coverage on shares of FibroGen Inc . (NASDAQ: FGEN ), currently valued at $32.76 million market cap, with a Buy rating and set a …

investing.com

$10
OFF

FibroGen Initiated With A Buy At H.C. Wainwright

2 weeks from now

Dec 17, 2024 · H.C. Wainwright initiated coverage of FibroGen with a Buy rating and $10 price target The company’s lead asset, FG-3246, is a novel antibody drug conjugate targeting CD46 …

businessinsider.com

$10.00
OFF

H.C. Wainwright Starts FibroGen (FGEN) At Buy

2 weeks from now

Dec 17, 2024 · H.C. Wainwright analyst Matt Keller initiates coverage on FibroGen (NASDAQ: FGEN) with a Buy rating and a price target of $10.00.The analyst comments...

streetinsider.com

$0.08
OFF

HC Wainwright Estimates FibroGen FY2024 Earnings

2 weeks from now

Dec 21, 2024 · HC Wainwright also issued estimates for FibroGen’s Q4 2024 earnings at ($0.08) EPS and FY2025 earnings at ($0.53) EPS. Get FibroGen alerts: A number of other equities …

etfdailynews.com

$0.44
OFF

HC Wainwright Forecasts FibroGen FY2026 Earnings

2 weeks from now

Dec 19, 2024 · HC Wainwright also issued estimates for FibroGen’s FY2027 earnings at ($0.44) EPS and FY2028 earnings at ($0.44) EPS. Get FibroGen alerts: Other analysts have also …

etfdailynews.com

FAQs about FibroGen (NASDAQ:FGEN) Upgraded at HC Wainwright Coupon?

Is HC Wainwright (FibroGen) a good stock to buy?

HC Wainwright has a “Strong-Buy” rating on the stock. The consensus estimate for FibroGen’s current full-year earnings is ($0.86) per share. HC Wainwright also issued estimates for FibroGen’s FY2027 earnings at ($0.44) EPS and FY2028 earnings at ($0.44) EPS. Other analysts have also issued reports about the stock. ...

How much will FibroGen (fgen) earn per share in fy2026?

FibroGen, Inc. (NASDAQ:FGEN – Free Report) – Stock analysts at HC Wainwright issued their FY2026 earnings per share estimates for shares of FibroGen in a research note issued on Tuesday, December 17th. HC Wainwright analyst M. Keller forecasts that the biopharmaceutical company will earn ($0.56) per share for the year. ...

Is FibroGen (fgen) a good stock to buy?

A number of research firms have changed their ratings and price targets for FibroGen (NASDAQ: FGEN): 12/24/2024 – FibroGen is now covered by analysts at StockNews.com. They set a “hold” rating on the stock. 12/17/2024 – FibroGen was upgraded by analysts at HC Wainwright to a “strong-buy” rating. 12/16/2024 – FibroGen is now covered by […] ...

How much did FibroGen (fgen) earn in a quarter?

FibroGen (NASDAQ:FGEN – Get Free Report) last posted its quarterly earnings results on Tuesday, November 12th. The biopharmaceutical company reported ($0.17) earnings per share for the quarter, topping the consensus estimate of ($0.38) by $0.21. ...

How much does FibroGen (fgen) cost?

The company has a 50 day moving average price of $0.36 and a two-hundred day moving average price of $0.55. FibroGen (NASDAQ:FGEN – Get Free Report) last posted its quarterly earnings results on Tuesday, November 12th. The biopharmaceutical company reported ($0.17) EPS for the quarter, beating the consensus estimate of ($0.38) by $0.21. ...

How do I receive news & ratings for FibroGen Inc?

Receive News & Ratings for FibroGen Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for FibroGen Inc and related companies with MarketBeat.com's FREE daily email newsletter. ...